Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb
ICD-10 C82.35 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiia, lymph nodes of inguinal region and lower limb.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIa indicates a higher degree of malignancy, with a greater number of large cells present in the tumor. This specific code pertains to cases where the lymphoma is localized to the lymph nodes in the inguinal region and lower limb. Patients may present with lymphadenopathy, which can be asymptomatic or associated with B-symptoms such as fever, night sweats, and weight loss. Diagnosis typically involves imaging studies, biopsy, and histological examination to confirm the presence of follicular lymphoma and assess the grade. Treatment options may include watchful waiting, chemotherapy, immunotherapy, or radiation therapy, depending on the stage of the disease and the patient's overall health. The prognosis varies based on the grade and extent of the disease, with grade IIIa generally indicating a more aggressive form of lymphoma that may require more intensive treatment.
Detailed pathology reports, treatment plans, and follow-up notes.
Diagnosis and management of newly diagnosed follicular lymphoma, treatment response assessments.
Ensure accurate grading and staging are documented to support coding.
Comprehensive biopsy reports and histological findings.
Evaluation of lymph node biopsies for lymphoma grading.
Clear documentation of cell types and grades is crucial for accurate coding.
Used when a biopsy is performed to confirm follicular lymphoma diagnosis.
Pathology report must clearly indicate the diagnosis and grade.
Pathologists should ensure accurate grading is documented.
Common treatments include chemotherapy, immunotherapy, and radiation therapy, often tailored to the patient's specific condition and overall health.